Form 4 Filing for Ring Christine
2026-05-01SEC Filing 4 (0001817199-26-000016)
Christine Ring, Chief Legal Officer of Nurix Therapeutics, Inc. (NRIX), reported the sale of 5,394 shares of Common Stock on May 1, 2026, pursuant to a Rule 10b5-1 trading plan. The weighted average sale price was $16.76 per share, with individual sales ranging from $16.26 to $16.97. Following this transaction, Ms. Ring directly owns 26,453 shares of Nurix Therapeutics, Inc. Common Stock.